Publication | Open Access
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
569
Citations
16
References
1995
Year
In this short-term study, ritonavir was well tolerated and had potent activity against HIV-1, but its clinical benefits remain to be established.
| Year | Citations | |
|---|---|---|
Page 1
Page 1